Literature DB >> 28936747

Exosomes: Outlook for Future Cell-Free Cardiovascular Disease Therapy.

Bahar Barani1, Sheeja Rajasingh1, Johnson Rajasingh2,3.   

Abstract

Cardiovascular diseases are the number one cause of death globally with an estimated 7.4 million people dying from coronary heart disease. Studies have been conducted to identify the therapeutic utility of exosomes in many diseases, including cardiovascular diseases. It has been demonstrated that exosomes are immune modulators, can be used to treat cardiac ischemic injury, pulmonary hypertension and many other diseases, including cancers. Exosomes can be used as a biomarker for disease and cell-free drug delivery system for targeting the cells. Many studies suggest that exosomes can be used as a cell-free vaccine for many diseases. In this chapter, we explore the possibility of future therapeutic potential of exosomes in various cardiovascular diseases.

Entities:  

Keywords:  Biomarker; Cardiovascular diseases; Drug delivery; Exosomes; Myocardial infarction; Nanovesicles

Mesh:

Substances:

Year:  2017        PMID: 28936747     DOI: 10.1007/978-981-10-4397-0_19

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  Exosomes from normal and diabetic human corneolimbal keratocytes differentially regulate migration, proliferation and marker expression of limbal epithelial cells.

Authors:  Aleksandra Leszczynska; Mangesh Kulkarni; Alexander V Ljubimov; Mehrnoosh Saghizadeh
Journal:  Sci Rep       Date:  2018-10-11       Impact factor: 4.379

Review 2.  Ischemia Reperfusion Injury: Mechanisms of Damage/Protection and Novel Strategies for Cardiac Recovery/Regeneration.

Authors:  Andrea Caccioppo; Luca Franchin; Alberto Grosso; Filippo Angelini; Fabrizio D'Ascenzo; Maria Felice Brizzi
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

Review 3.  Role of Human Mesenchymal Stem Cells in Regenerative Therapy.

Authors:  Jayavardini Vasanthan; Narasimman Gurusamy; Sheeja Rajasingh; Vinoth Sigamani; Shivaani Kirankumar; Edwin L Thomas; Johnson Rajasingh
Journal:  Cells       Date:  2020-12-31       Impact factor: 6.600

Review 4.  Immune Cells and Immunotherapy for Cardiac Injury and Repair.

Authors:  Joel G Rurik; Haig Aghajanian; Jonathan A Epstein
Journal:  Circ Res       Date:  2021-05-27       Impact factor: 23.213

Review 5.  Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.

Authors:  Kaavya Jayaramayya; Iyer Mahalaxmi; Mohana Devi Subramaniam; Neethu Raj; Ahmed Abdal Dayem; Kyung Min Lim; Se Jong Kim; Jong Yub An; Yoonjoo Lee; Yujin Choi; Arthi Raj; Ssang-Goo Cho; Balachandar Vellingiri
Journal:  BMB Rep       Date:  2020-08       Impact factor: 4.778

Review 6.  Stem cell-derived biofactors fight against coronavirus infection.

Authors:  Mohammadreza Ardalan; Leila Chodari; Sepideh Zununi Vahed; Seyed Mahdi Hosseiniyan Khatibi; Aziz Eftekhari; Soodabeh Davaran; Magali Cucchiarini; Leila Roshangar; Elham Ahmadian
Journal:  World J Stem Cells       Date:  2021-12-26       Impact factor: 5.326

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.